Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
European Journal of Endocrinology|August 18, 2009
Cardiovascular risk factors in hypopituitary GH-deficient adultsJohan Verhelst, Roger AbsTreatments in Endocrinology|May 6, 2005
Hyperprolactinemia: pathophysiology and managementJohan Verhelst, Roger AbsDrugs|October 25, 2002
Long-term growth hormone replacement therapy in hypopituitary adultsJohan Verhelst, Roger AbsActa Cardiologica|February 21, 2006
Cardiomyopathy and thyrotoxicosis: tachycardiomyopathy or thyrotoxic cardiomyopathy?Tom Vydt, Johan Verhelst, Gilles De KeulenaerEuropean Journal of Endocrinology|February 19, 2009
Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patientsEtienne Delgrange, Tania Daems, Johan Verhelst, et al.Clinical Rheumatology|October 2, 2009
Flexion contractures in secondary adrenal insufficiencyJan Berger, Piet Herregods, Johan Verhelst, et al.European Journal of Endocrinology|November 7, 2007
Optimalization and cost management of lanreotide-Autogel therapy in acromegalyPascale Abrams, Orsalia Alexopoulou, Roger Abs, et al.Endocrine Connections|April 18, 2018
The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysisJohan Verhelst, Anders F Mattsson, Cecilia Camacho-Hübner, et al.Pituitary|March 20, 2008
Modification of hormonal secretion in clinically silent pituitary adenomasTania Daems, Johan Verhelst, Alex Michotte, et al.Diabetes Care|November 15, 2011
Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational studyAnton Luger, Anders F Mattsson, Maria Koltowska-Häggström, et al.Pageof 2